AbbVie
ABBV
1,600 hedge funds and large institutions have $65.3B invested in AbbVie in 2015 Q1 according to their latest regulatory filings, with 132 funds opening new positions, 684 increasing their positions, 578 reducing their positions, and 115 closing their positions.
34% more call options, than puts
Call options by funds: $1.09B | Put options by funds: $815M
18% more repeat investments, than reductions
Existing positions increased: 684 | Existing positions reduced: 578
15% more first-time investments, than exits
New positions opened: 132 | Existing positions closed: 115
0% less funds holding
Funds holding: 1,604 → 1,600 (-4)
0.53% less ownership
Funds ownership: 70.51% → 69.98% (-0.53%)
11% less capital invested
Capital invested by funds: $73.6B → $65.3B (-$8.29B)
14% less funds holding in top 10
Funds holding in top 10: 94 → 81 (-13)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$295M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$216M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$197M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$181M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$168M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$766M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$610M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$577M |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$378M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$308M |
ABBV Hedge Fund Activity: Q1 2015 in Review
1,600 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q1 2015, worth a combined $65.3B — down 11% from $73.6B a quarter earlier.
Buyers outnumbered sellers: 132 funds opened new ABBV positions and 115 closed out — a net gain of 17 holders — while 684 added to existing stakes and 578 trimmed.
The largest buyer was Janus Henderson Investors US, adding an estimated $295M. The largest seller was Fidelity Investments, cutting an estimated $766M.
- 1,600 institutional investors held AbbVie (ABBV) as of Q1 2015, down from 1,604 in Q4 2014.
- Funds reported $65.3B of AbbVie stock for Q1 2015, down 11% quarter-over-quarter.
- 132 funds opened new AbbVie positions in Q1 2015 and 115 closed out, a net change of +17 holders.
- The largest AbbVie buyer in Q1 2015 was Janus Henderson Investors US, an estimated $295M added.
- The largest AbbVie seller in Q1 2015 was Fidelity Investments, an estimated $766M sold.
Based on aggregated 13F filings for Q1 2015.